Federal Government Funds The Canadian Adaptive Platform Trial of Treatments for COVID-19 in Community Settings (CanTreatCOVID)

July 26, 2022

The CanTreatCOVID study, led by our lab director, Dr. Andrew Pinto has secured $10 million in funding. This COVID-19 study will evaluate the effectivity of oral medications for acute COVID-19 infections and examine if the risk of long COVID can be reduced by these oral treatments.


“By developing cross-country infrastructure and relationships, we’ll be uniquely positioned to study treatments for other pathogens and diseases in the community well beyond the COVID-19 pandemic.” – Dr. Andrew Pinto

CanTreatCOVID Website

Browse by Category

From the Archives